Alfa Scientific Designs, Inc., Pledges to Reach 80% Screened for Colorectal Cancer

Company joins the National Colorectal Cancer Roundtable to meet goal by 2018.

Alfa Scientific Designs, Inc., Pledges to Reach 80% Screened for Colorectal Cancer
Poway, CA, March 21, 2017 --(PR.com)-- Alfa Scientific Designs, Inc., (ALFA), a leader in the development and manufacturing of rapid immunoassay point-of-care tests, has partnered with the National Colorectal Cancer Roundtable (NCCRT) to support efforts to increase the number of people screened for colorectal cancer and substantially reduce colorectal cancer as a major public health problem.

“We are proud to join forces with more than 500 local and national organizations to help to increase colorectal cancer (CRC) screening rates by supporting the 80% by 2018 initiative," said Dr. Chai Bunygidj, PhD., COO & General Manager. “Our rapid, point-of-care immunochemical fecal occult blood (iFOB) test for CRC pre-screening is widely available not only to clinicians and hospitals, but everyone because it can be purchased over-the-counter for easy at-home use.”

Colon cancer is the nation’s second-leading cause of cancer-related deaths; however it is one of only a few cancers that can be prevented. Colon cancer screening helps save lives by detecting polyps early so they can be removed before they become cancerous. Early detection through screening is invaluable and continues to play a pivotal role in the lives of more than 1 million colorectal cancer survivors across the nation.

Alfa Scientific Designs, Inc., is one of the first companies to offer an over-the-counter (OTC) Fecal Occult Blood test (FOBT) for colon cancer pre-screening. In just few short, simple steps, an FOBT can be performed in the privacy and comfort of the patient’s home. With unprecedented speed and 99.5% accuracy, results are seen as quickly as one minute.

For more information, visit www.alfascientific.com.

About Alfa Scientific Designs
Alfa Scientific Designs, Inc., is a leader in the development and manufacturing of rapid immunoassay point-of-care tests. It offers a broad range of services, including contract product development, technology transfer, OEM services, custom assembly, and packaging with private labeling, all performed in the U.S.A. Established in 1996, ALFA develops breakthrough designs produced to the highest quality standards. The ALFA Product line is U.S. FDA Regulated and ISO Certified. For more information, visit https://www.alfascientific.com/.
Contact
Alfa Scientific Designs, Inc.
Jeanette Christian - Marketing Communications
858-413-1276
www.alfascientific.com
ContactContact
Multimedia
Categories